+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Human Diseases"

From
Therapeutic Fc-Fusion Proteins. Edition No. 1 - Product Thumbnail Image

Therapeutic Fc-Fusion Proteins. Edition No. 1

  • Book
  • February 2014
  • 400 Pages
Genetic Analysis of Complex Disease. Edition No. 3 - Product Thumbnail Image

Genetic Analysis of Complex Disease. Edition No. 3

  • Book
  • January 2022
  • 336 Pages
Basic Virology. Edition No. 4 - Product Thumbnail Image

Basic Virology. Edition No. 4

  • Book
  • May 2021
  • 576 Pages
Loading Indicator

The Human Diseases market is a subset of the Biology and Life Sciences industry that focuses on the diagnosis, treatment, and prevention of diseases in humans. It includes research and development of drugs, medical devices, and diagnostics, as well as the delivery of healthcare services. This market is driven by advances in medical technology, the emergence of new diseases, and the need for better treatments. It is also influenced by the availability of healthcare resources, the cost of treatments, and the changing demographics of the population. The Human Diseases market is highly competitive, with a range of players from large pharmaceutical companies to small biotechnology firms. Companies in this market include Pfizer, Merck, Novartis, Johnson & Johnson, Roche, Sanofi, AstraZeneca, GlaxoSmithKline, AbbVie, and Bristol-Myers Squibb. Show Less Read more